PRF Tech (PRFX)
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible...
- Open
- 1.070
- High
- 1.080
- Low
- 1.040
- Prev. Close
- 1.050
- Volume
- 25.40K
- Turnover
- 26.75K
- Avg Price
- 1.053
- Bid/Ask Ratio
- -53.86%
- Amplitude
- 3.81%
- 52wk High
- 17.950
- Volume Ratio
- 0.19
- Turnover Ratio
- 3.40%
PRF Tech Analyst Rating
View moreForecast & Rating
Nov 20, 2024Price forecast
$240.0022541.50%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · 8 hours ago
Rolls-Royce and InterDigital Raise 2026 Forecasts as AI and Licensing Revenues Surge
- Global Report · Aug 1 at 04:14 AM
Fringe Assets Amid Macro Divergence: From Arbitrage ETFs to the Downside Risks of Micro-Caps
- PUBT · Jul 27 at 07:48 AM
PRF Technologies readies Phase 2 trial of LayerBio’s OcuRing-K cataract surgery implant
- Tip Ranks · Jul 21 at 08:18 AM
PRF Technologies to Present AI-Powered GridFeed Platform at Energy Trading Week Europe 2026
- StockTitan · Jul 15 at 12:15 AM
PRF Technologies Expands DeepSolar Predict™ Platform with Battery-to-Revenue Intelligence, Extending AI-Driven Revenue Optimization Across Solar and Energy Storage Assets | PRFX Stock News
- PUBT · Jul 8 at 07:32 AM
PRF Technologies announces press release availability on DeepSolar Predict AI platform validation
